Arqule Inc Revenue Growth Rates (ARQL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Arqule Inc  (ARQL)
 

ARQL's Revenue Growth by Quarter and Year

Arqule Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARQL Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September 0.21
2nd Quarter June 0.28
1st Quarter March 1.35
FY 1.84

ARQLs Annual Revenue
Arqule Inc's Revenue in the fiscal year 2018 $ 25.76 millions
Arqule Inc's Revenue in the fiscal year 2017 $ 0.00 millions
Arqule Inc's Revenue in the fiscal year 2016 $ 4.71 millions
Arqule Inc's Revenue in the fiscal year 2015 $ 11.24 millions
Arqule Inc's Revenue in the fiscal year 2014 $ 11.25 millions




ARQL Revenue third quarter 2019 Y/Y Growth Comment
Arqule Inc reported drop in Revenue in the third quarter 2019 by -95.82% to $ 0.21 millions, from the same quarter in 2018.
The fall in the third quarter 2019 Arqule Inc's Revenue compares unfavorably to the Company's average Revenue drop of -46.34%.

Looking into third quarter 2019 results within Major Pharmaceutical Preparations industry 221 other companies have achieved higher Revenue growth. While Arqule Inc' s Revenue meltdown of -95.82% ranks overall at the positon no. 3980 in the third quarter 2019.


ARQL Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - - - -
3rd Quarter September -95.82 % - - -
2nd Quarter June -97.96 % - - -64.33 %
1st Quarter March -67.39 % - - -55.91 %
FY   - - - -

Financial Statements
Arqule Inc's third quarter 2019 Revenue $ 0.21 millions ARQL's Income Statement
Arqule Inc's third quarter 2018 Revenue $ 4.98 millions Quarterly ARQL's Income Statement


ARQL Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - -40.96 % - -
3rd Quarter September -25.71 % -63.68 % - -
2nd Quarter June -79.26 % 231.16 % - -13.01 %
1st Quarter March -54.08 % - - -56.07 %
FY (Year on Year)   - - - -


Back to ARQL Growth rate Comparisons >> Back to ARQL Growth rate Comparisons >>


Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #222
Healthcare Sector #543
Overall #3980

Revenue Y/Y Growth Statistics
High Average Low
32.53 % -46.34 % -100 %
(Dec 31 2014)   (Jun 30 2017)
Revenue third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #222
Healthcare Sector #543
Overall #3980
Revenue Y/Y Growth Statistics
High Average Low
32.53 % -46.34 % -100 %
(Dec 31 2014)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Arqule Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
231.22 % -7.18 % -79.11 %
(Jun 30 2018)  


ARQL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Arqule Inc disclosed fall in Revenue from the second quarter by -25.71% to $ 0.21 millions, from $ 0.28 millions achived in the previous reporting period.

But that's not important problem, as Arqule Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 215 other companies have achieved higher Revenue quarter on quarter growth. While Arqule Inc's Revenue growth quarter on quarter, overall rank is 3917.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #216
Healthcare Sector #530
Overall #3917
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #216
Healthcare Sector #530
Overall #3917
Revenue Q/Q Growth Statistics
High Average Low
231.22 % -7.18 % -79.11 %
(Jun 30 2018)  


ARQL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2019 Arqule Inc disclosed fall in Revenue from the second quarter by -25.71% to $ 0.21 millions, from $ 0.28 millions achived in the previous reporting period.

But that's not important problem, as Arqule Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 215 other companies have achieved higher Revenue quarter on quarter growth. While Arqule Inc's Revenue growth quarter on quarter, overall rank is 3917.


Arqule Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)
Cumulative Revenue 12 Months Ending $ 4.78 $ 9.55 $ 22.97 $ 25.76 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -49.98 % -58.44 % -10.84 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 3097 # 3407 # 849 # 0 # 0


Cumulative Revenue growth Comment


Arqule Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 160
Sector # 391
S&P 500 # 3097
Cumulative Revenue growth Comment


Arqule Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 160
Sector # 391
S&P 500 # 3097




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ARQL's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2019
Waters Corporation-0.13%$ -0.129 millions
Vaso Corporation-0.32%$ -0.325 millions
Nature s Sunshine Products inc -0.34%$ -0.342 millions
Myomo Inc -0.39%$ -0.388 millions
Integer Holdings Corporation-0.49%$ -0.492 millions
Prestige Consumer Healthcare Inc -0.54%$ -0.538 millions
Dariohealth Corp -0.59%$ -0.585 millions
Alpha Pro Tech Ltd -0.64%$ -0.636 millions
Vivus Inc-0.65%$ -0.652 millions
Aptinyx Inc -0.74%$ -0.742 millions
Supernus Pharmaceuticals inc -0.83%$ -0.831 millions
Pediatrix Medical Group Inc -0.89%$ -0.890 millions
Atrion Corporation-1.00%$ -0.996 millions
Livanova Plc-1.28%$ -1.276 millions
Assembly Biosciences Inc -1.28%$ -1.280 millions
Magellan Health inc -1.33%$ -1.325 millions
Rvl Pharmaceuticals Plc-1.33%$ -1.332 millions
Scientific Industries Inc -1.69%$ -1.687 millions
3m Company-1.97%$ -1.975 millions
Endo International Plc-2.15%$ -2.152 millions
Intersect Ent Inc -2.47%$ -2.473 millions
Nymox Pharmaceutical Corporation-2.50%$ -2.500 millions
United Therapeutics Corporation-2.71%$ -2.714 millions
Amgen Inc -2.83%$ -2.829 millions
Envista Holdings Corporation-2.97%$ -2.973 millions
Arcturus Therapeutics Holdings Inc -3.07%$ -3.067 millions
Theravance Biopharma inc -3.20%$ -3.201 millions
Autolus Therapeutics Plc-3.26%$ -3.257 millions
Enovis Corp-3.30%$ -3.296 millions
Musclepharm Corporation-3.46%$ -3.465 millions


About Arqule Inc Revenue Growth Rates (ARQL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.